
                     
                     
                     Drug Interactions
                     
                        
                           
                              Selective Serotonin Reuptake Inhibitors/Serotonin 
                           
                        
                        
                           
                              Norepinephrine Reuptake Inhibitors and Serotonin Syndrome: 
                           Cases of life-threatening serotonin syndrome have been reported during combined use of SSRIs or SNRIs and triptans (see WARNINGS).
                        
                           
                              Ergot-Containing Drugs: 
                           Ergot-containing drugs have been reported to cause prolonged vasospastic reactions. Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or methysergide) and sumatriptan within 24 hours of each other should be avoided (see CONTRAINDICATIONS).
                        
                           
                              Monoamine Oxidase-A Inhibitors: 
                           MAO-A inhibitors reduce sumatriptan clearance, significantly increasing systemic exposure. Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated (see CLINICAL PHARMACOLOGY and CONTRAINDICATIONS).Â 
                  
                     
                     
                  
               